Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Surgical Management of Chronic Pulmonary Regurgitation After Relief of Right Ventricular Outflow Tract Obstruction

  • Lee, Cheul (Department of Thoracic and Cardiovascular Surgery, Cardiovascular Center, Sejong General Hospital)
  • Published : 2012.01.31
⟨ Previous Next ⟩

Abstract

Relief of right ventricular (RV) outflow tract obstruction in tetralogy of Fallot or similar physiology often results in pulmonary regurgitation (PR). The resultant chronic volume overload can lead to RV dilatation, biventricular dysfunction, heart failure symptoms, arrhythmias and sudden death. Although pulmonary valve replacement (PVR) can lead to improvement in the functional class and a substantial decrease or normalization of RV volumes, the optimal timing of PVR is not well defined. Benefits of PVR have to be weighed against the risks of this procedure including subsequent reoperation. This article reviews the pathophysiology of chronic PR, evidence-based benefits and risks of PVR, options for valve substitute, and optimal timing of PVR in patients with chronic PR after relief of RV outflow tract obstruction.

Keywords

References

  1. Murphy JG, Gersh BJ, Mair DD, et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 1993;329:593-9. https://doi.org/10.1056/NEJM199308263290901
  2. Therrien J, Marx GR, Gatzoulis MA. Late problems in tetralogy of Fallot: recognition, management, and prevention. Cardiol Clin 2002;20:395-404. https://doi.org/10.1016/S0733-8651(02)00010-3
  3. Gatzoulis MA, Balaji S, Webber SA, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet 2000;356:975-81. https://doi.org/10.1016/S0140-6736(00)02714-8
  4. Geva T, Sandweiss BM, Gauvreau K, Lock JE, Powell AJ. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol 2004;43:1068-74. https://doi.org/10.1016/j.jacc.2003.10.045
  5. Bouzas B, Kilner PJ, Gatzoulis MA. Pulmonary regurgitation: not a benign lesion. Eur Heart J 2005;26:433-9.
  6. Cheung EW, Wong WH, Cheung YF. Meta-analysis of pulmonary valve replacement after operative repair of tetralogy of fallot. Am J Cardiol 2010;106:552-7. https://doi.org/10.1016/j.amjcard.2010.03.065
  7. Geva T, Gauvreau K, Powell AJ, et al. Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery. Circulation 2010;122(11 Suppl):S201-8. https://doi.org/10.1161/CIRCULATIONAHA.110.951178
  8. Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson 2011;13:9. https://doi.org/10.1186/1532-429X-13-9
  9. Samyn MM, Powell AJ, Garg R, Sena L, Geva T. Range of ventricular dimensions and function by steady-state free precession cine MRI in repaired tetralogy of Fallot: right ventricular outflow tract patch vs. conduit repair. J Magn Reson Imaging 2007;26:934-40. https://doi.org/10.1002/jmri.21094
  10. Helbing WA, Niezen RA, Le Cessie S, van der Geest RJ, Ottenkamp J, de Roos A. Right ventricular diastolic function in children with pulmonary regurgitation after repair of tetralogy of Fallot: volumetric evaluation by magnetic resonance velocity mapping. J Am Coll Cardiol 1996;28:1827-35. https://doi.org/10.1016/S0735-1097(96)00387-7
  11. Helbing WA, de Roos A. Clinical applications of cardiac magnetic resonance imaging after repair of tetralogy of Fallot. Pediatr Cardiol 2000;21:70-9. https://doi.org/10.1007/s002469910009
  12. Knauth AL, Gauvreau K, Powell AJ, et al. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart 2008;94:211-6. https://doi.org/10.1136/hrt.2006.104745
  13. Sanchez-Quintana D, Anderson RH, Ho SY. Ventricular myoarchitecture in tetralogy of Fallot. Heart 1996;76:280-6. https://doi.org/10.1136/hrt.76.3.280
  14. Davlouros PA, Kilner PJ, Hornung TS, et al. Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol 2002;40:2044-52. https://doi.org/10.1016/S0735-1097(02)02566-4
  15. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol 1998;32:245-51. https://doi.org/10.1016/S0735-1097(98)00187-9
  16. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot: QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation 1995;92:231-7. https://doi.org/10.1161/01.CIR.92.2.231
  17. Harrison DA, Harris L, Siu SC, et al. Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot. J Am Coll Cardiol 1997;30:1368-73. https://doi.org/10.1016/S0735-1097(97)00316-1
  18. Dave HH, Buechel ER, Dodge-Khatami A, et al. Early insertion of a pulmonary valve for chronic regurgitation helps restoration of ventricular dimensions. Ann Thorac Surg 2005;80:1615-20. https://doi.org/10.1016/j.athoracsur.2005.04.058
  19. Oosterhof T, van Straten A, Vliegen HW, et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 2007;116:545-51. https://doi.org/10.1161/CIRCULATIONAHA.106.659664
  20. Frigiola A, Tsang V, Bull C, et al. Biventricular response after pulmonary valve replacement for right ventricular outflow tract dysfunction: is age a predictor of outcome? Circulation 2008;118(14 Suppl):S182-90. https://doi.org/10.1161/CIRCULATIONAHA.107.756825
  21. Lim C, Lee JY, Kim WH, et al. Early replacement of pulmonary valve after repair of tetralogy: is it really beneficial? Eur J Cardiothorac Surg 2004;25:728-34. https://doi.org/10.1016/j.ejcts.2004.01.036
  22. Scherptong RW, Hazekamp MG, Mulder BJ, et al. Follow-up after pulmonary valve replacement in adults with tetralogy of Fallot: association between QRS duration and outcome. J Am Coll Cardiol 2010;56:1486-92. https://doi.org/10.1016/j.jacc.2010.04.058
  23. Ghez O, Tsang VT, Frigiola A, et al. Right ventricular outflow tract reconstruction for pulmonary regurgitation after repair of tetralogy of Fallot: preliminary results. Eur J Cardiothorac Surg 2007;31:654-8. https://doi.org/10.1016/j.ejcts.2006.12.031
  24. Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 2005;95:779-82. https://doi.org/10.1016/j.amjcard.2004.11.037
  25. Frigiola A, Giamberti A, Chessa M, et al. Right ventricular restoration during pulmonary valve implantation in adults with congenital heart disease. Eur J Cardiothorac Surg 2006;29(Suppl 1): S279-85. https://doi.org/10.1016/j.ejcts.2006.03.007
  26. Harrild DM, Berul CI, Cecchin F, et al. Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation 2009;119:445-51. https://doi.org/10.1161/CIRCULATIONAHA.108.775221
  27. Vliegen HW, van Straten A, de Roos A, et al. Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of fallot. Circulation 2002;106:1703-7. https://doi.org/10.1161/01.CIR.0000030995.59403.F8
  28. Therrien J, Siu SC, Harris L, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 2001;103:2489-94. https://doi.org/10.1161/01.CIR.103.20.2489
  29. Doughan AR, McConnell ME, Lyle TA, Book WM. Effects of pulmonary valve replacement on QRS duration and right ventricular cavity size late after repair of right ventricular outflow tract obstruction. Am J Cardiol 2005;95:1511-4. https://doi.org/10.1016/j.amjcard.2005.01.100
  30. Gengsakul A, Harris L, Bradley TJ, et al. The impact of pulmonary valve replacement after tetralogy of Fallot repair: a matched comparison. Eur J Cardiothorac Surg 2007;32:462-8. https://doi.org/10.1016/j.ejcts.2007.06.009
  31. Dos L, Dadashev A, Tanous D, et al. Pulmonary valve replacement in repaired tetralogy of Fallot: determinants of early postoperative adverse outcomes. J Thorac Cardiovasc Surg 2009;138:553-9. https://doi.org/10.1016/j.jtcvs.2009.02.042
  32. Borger MA, Ivanov J, Armstrong S, Christie-Hrybinsky D, Feindel CM, David TE. Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis 2006;15:49-55.
  33. McClure RS, Narayanasamy N, Wiegerinck E, et al. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients. Ann Thorac Surg 2010;89:1410-6. https://doi.org/10.1016/j.athoracsur.2010.01.046
  34. Discigil B, Dearani JA, Puga FJ, et al. Late pulmonary valve replacement after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 2001;121:344-51. https://doi.org/10.1067/mtc.2001.111209
  35. Caldarone CA, McCrindle BW, Van Arsdell GS, et al. Independent factors associated with longevity of prosthetic pulmonary valves and valved conduits. J Thorac Cardiovasc Surg 2000;120:1022-30. https://doi.org/10.1067/mtc.2000.110684
  36. Konakci KZ, Bohle B, Blumer R, et al. Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery. Eur J Clin Invest 2005;35:17-23. https://doi.org/10.1111/j.1365-2362.2005.01441.x
  37. Manji RA, Zhu LF, Nijjar NK, et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation 2006;114:318-27. https://doi.org/10.1161/CIRCULATIONAHA.105.549311
  38. Park CS, Park SS, Choi SY, Yoon SH, Kim WH, Kim YJ. Anti alphagal immune response following porcine bioprosthesis implantation in children. J Heart Valve Dis 2010;19:124-30.
  39. Lee C, Park CS, Lee CH, et al. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg 2011;142:351-8. https://doi.org/10.1016/j.jtcvs.2010.12.020
  40. Fiore AC, Rodefeld M, Turrentine M, et al. Pulmonary valve replacement: a comparison of three biological valves. Ann Thorac Surg 2008;85:1712-8. https://doi.org/10.1016/j.athoracsur.2008.02.001
  41. Kanter KR, Budde JM, Parks WJ, et al. One hundred pulmonary valve replacements in children after relief of right ventricular outflow tract obstruction. Ann Thorac Surg 2002;73:1801-6. https://doi.org/10.1016/S0003-4975(02)03568-3
  42. Allen BS, El-Zein C, Cuneo B, Cava JP, Barth MJ, Ilbawi MN. Pericardial tissue valves and Gore-Tex conduits as an alternative for right ventricular outflow tract replacement in children. Ann Thorac Surg 2002;74:771-7. https://doi.org/10.1016/S0003-4975(02)03767-0
  43. Morales DL, Braud BE, DiBardino DJ, et al. Perimount bovine pericardial valve to restore pulmonary valve competence late after right ventricular outflow tract repair. Congenit Heart Dis 2007;2:115-20. https://doi.org/10.1111/j.1747-0803.2007.00083.x
  44. Hawkins JA, Sower CT, Lambert LM, et al. Stentless porcine valves in the right ventricular outflow tract: improved durability? Eur J Cardiothorac Surg 2009;35:600-4. https://doi.org/10.1016/j.ejcts.2008.12.028
  45. Kanter KR, Fyfe DA, Mahle WT, Forbess JM, Kirshbom PM. Results with the freestyle porcine aortic root for right ventricular outflow tract reconstruction in children. Ann Thorac Surg 2003;76:1889-94. https://doi.org/10.1016/S0003-4975(03)01304-3
  46. Yemets IM, Williams WG, Webb GD, et al. Pulmonary valve replacement late after repair of tetralogy of Fallot. Ann Thorac Surg 1997;64:526-30. https://doi.org/10.1016/S0003-4975(97)00577-8
  47. Van de Woestijne PC, Mokhles MM, de Jong PL, Witsenburg M, Takkenberg JJ, Bogers AJ. Right ventricular outflow tract reconstruction with an allograft conduit in patients after tetralogy of Fallot correction: long-term follow-up. Ann Thorac Surg 2001;92:161-6.
  48. Oosterhof T, Meijboom FJ, Vliegen HW, et al. Long-term follow-up of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot. Eur Heart J 2006;27:1478-84.
  49. Rosti L, Murzi B, Colli AM, et al. Mechanical valves in the pulmonary position: a reappraisal. J Thorac Cardiovasc Surg 1998;115:1074-9. https://doi.org/10.1016/S0022-5223(98)70407-6
  50. Waterbolk TW, Hoendermis ES, den Hamer IJ, Ebels T. Pulmonary valve replacement with a mechanical prosthesis: promising results of 28 procedures in patients with congenital heart disease. Eur J Cardiothorac Surg 2006;30:28-32. https://doi.org/10.1016/j.ejcts.2006.02.069
  51. Stulak JM, Dearani JA, Burkhart HM, et al. The increasing use of mechanical pulmonary valve replacement over a 40-year period. Ann Thorac Surg 2010;90:2009-14. https://doi.org/10.1016/j.athoracsur.2010.07.023
  52. Quintessenza JA, Jacobs JP, Morell VO, Giroud JM, Boucek RJ. Initial experience with a bicuspid polytetrafluoroethylene pulmonary valve in 41 children and adults: a new option for right ventricular outflow tract reconstruction. Ann Thorac Surg 2005;79:924-31. https://doi.org/10.1016/j.athoracsur.2004.05.045
  53. Quintessenza JA. Polytetrafluoroethylene bicuspid pulmonary valve implantation. Oper Tech Thorac Cardiovasc Surg 2009;13:244-9.
  54. Brown JW, Ruzmetov M, Vijay P, Rodefeld MD, Turrentine MW. Right ventricular outflow tract reconstruction with a polytetrafluoroethylene monocusp valve: a twelve-year experience. J Thorac Cardiovasc Surg 2007;133:1336-43. https://doi.org/10.1016/j.jtcvs.2006.12.045
  55. Quintessenza JA, Jacobs JP, Chai PJ, Morell VO, Lindberg H. Polytetrafluoroethylene bicuspid pulmonary valve implantation experience with 126 patients. World J Pediatr Congenit Heart Surg 2010;1:20-7. https://doi.org/10.1177/2150135110361509
  56. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation 2008;118:2395-451. https://doi.org/10.1161/CIRCULATIONAHA.108.190811
  57. Henkens IR, van Straten A, Schalij MJ, et al. Predicting outcome of pulmonary valve replacement in adult tetralogy of Fallot patients. Ann Thorac Surg 2007;83:907-11. https://doi.org/10.1016/j.athoracsur.2006.09.090

Cited by

  1. The echocardiographic paradox index in patients with a repaired tetralogy of Fallot vol.48, pp.2, 2012, https://doi.org/10.3109/14017431.2014.884723
  2. The Effect of Pulmonary Valve Replacement (PVR) Surgery on Hemodynamics of Patients Who Underwent Repair of Tetralogy of Fallot (TOF) vol.7, pp.3, 2012, https://doi.org/10.15171/jcvtr.2015.26
  3. Mid-term outcomes of mechanical pulmonary valve replacement: a single-institutional experience of 396 patients vol.67, pp.3, 2019, https://doi.org/10.1007/s11748-018-1012-0
  4. Pregnancy outcomes among 31 patients with tetralogy of Fallot, a retrospective study vol.19, pp.1, 2012, https://doi.org/10.1186/s12884-019-2630-y
  5. Evolving Techniques for the Achievement of Optimal Long-Term Results After Tetralogy of Fallot Repair vol.12, pp.1, 2012, https://doi.org/10.1177/2150135120968103